Cipher Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Cipher Pharmaceuticals Inc. is publicly traded on TSX under the ticker CPH.TO.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis;...
Can you invest in Cipher Pharmaceuticals Inc.?
Yes. Cipher Pharmaceuticals Inc. is publicly traded on TSX under the ticker CPH.TO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cipher Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.